E-ISSN: 2619-9467

Contents    Cover    Publication Date: 31 Aug 2018
Year 2018 - Volume 28 - Issue 2

Open Access

Peer Reviewed

1742 Viewed678 Downloaded

Postpartum Plasmapheresis Treatment in a Severe Liver Enzyme Disorder

J Clin Obstet Gynecol. 2018;28(2):75-7
DOI: 10.5336/gynobstet.2015-46783
Article Language: EN
Copyright Ⓒ 2020 by Türkiye Klinikleri. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
HELLP syndrome is a severe form of preeclampsia that was first described by Weinstein in 1982. It is characterized by hemolysis, elevated liver enzymes, and low platelet count. HELLP develops in approximately 0.5-0.9% of all pregnancies and in 10-20% of pregnancies complicated with preeclampsia. HELLP syndrome is a severe complication that increases the risk of both fetal and maternal mortality. The treatment for HELLP syndrome is primarily based on the gestational age, and though the most effective treatment is delivery, other options are also available. Plasmapheresis is the preferred option for the complication of progressive liver function disorder. We present a case report of a 34-year-old pregnant woman suffering from HELLP syndrome, who showed dramatic improvement after plasmapheresis.